Briacell Therapeutics Corp Stock Price on April 27, 2023
If you're considering investing in Briacell Stock, it is important to understand the factors that can impact its price. Briacell Therapeutics appears to be very risky, given 3 months investment horizon. Briacell Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0223, which signifies that the company had a 0.0223% return per unit of risk over the last 3 months. We have found twenty-one technical indicators for Briacell Therapeutics Corp, which you can use to evaluate the volatility of the firm. Please makes use of Briacell Therapeutics' Downside Deviation of 10.93, mean deviation of 8.05, and Risk Adjusted Performance of 0.0272 to double-check if our risk estimates are consistent with your expectations.
Briacell Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Briacell |
Sharpe Ratio = 0.0223
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | BCTX | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
12.36 actual daily | 96 96% of assets are less volatile |
Expected Return
0.28 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Briacell Therapeutics is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Briacell Therapeutics by adding it to a well-diversified portfolio.
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Price Boundaries
Briacell Therapeutics Period Price Range
Low | December 25, 2024
| High |
0.00 | 0.00 |
Briacell Therapeutics Corp cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Briacell Therapeutics December 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Briacell Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Briacell Therapeutics shares will generate the highest return on investment. By undertsting and applying Briacell Therapeutics stock market strength indicators, traders can identify Briacell Therapeutics Corp entry and exit signals to maximize returns
Briacell Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Briacell Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Briacell Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Briacell to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0272 | |||
Jensen Alpha | 0.2537 | |||
Total Risk Alpha | (0.27) | |||
Sortino Ratio | 0.0211 | |||
Treynor Ratio | 0.7852 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Tools for Briacell Stock
When running Briacell Therapeutics' price analysis, check to measure Briacell Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Briacell Therapeutics is operating at the current time. Most of Briacell Therapeutics' value examination focuses on studying past and present price action to predict the probability of Briacell Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Briacell Therapeutics' price. Additionally, you may evaluate how the addition of Briacell Therapeutics to your portfolios can decrease your overall portfolio volatility.
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |